Skip to main content
Top
Published in: Supportive Care in Cancer 10/2007

Open Access 01-10-2007 | Supportive Care International

The last 3 days of life in three different care settings in The Netherlands

Authors: Laetitia Veerbeek, Lia van Zuylen, Siebe J. Swart, Paul J. van der Maas, Agnes van der Heide

Published in: Supportive Care in Cancer | Issue 10/2007

Login to get access

Abstract

Introduction

Little is known about the characteristics of dying in different care settings, such as the hospital, the nursing home, or the home-care setting.

Materials and methods

We measured the burden of symptoms, medical and nursing interventions, and aspects of communication during the last 3 days of life within each of these settings. We included 239 of 321 patients (74%) who died in one of these settings in the southwest of The Netherlands, between November 2003 and February 2005. After the patient’s death, a nurse filled in a questionnaire.

Results

Pain and shortness of breath were more severe in hospital patients as compared to nursing home and home-care patients, whereas incontinence was less severe in hospital patients. Several medical interventions, such as a syringe driver, vena punctures or lab tests, radiology or ECG, antibiotics, and drainage of body fluids were more often applied during the last 3 days of life to hospital patients than to nursing home and home-care patients. This also holds for the measurement of body temperature and blood pressure. In the hospital setting, the patient and the family were more often informed about the imminence of death of the patient than elsewhere. The general practitioner and other professional caregivers were less often informed about the imminence of death of hospital patients than of other patients.

Discussion

We conclude that pain and shortness of breath were more severe among hospital patients, whereas incontinence was more severe among nursing home and home-care patients. Hospital patients relatively often receive medical interventions and standard controls during the last 3 days of life. In hospital, communication about impending death seems to take place more often shortly before death.
Literature
1.
go back to reference Higginson IJ, Sen-Gupta GJ (2000) Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med 3(3):287–300PubMedCrossRef Higginson IJ, Sen-Gupta GJ (2000) Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med 3(3):287–300PubMedCrossRef
2.
go back to reference WHO Europe (2004) Evidence of underassessment and undertreatment. In: Davies E, Higginson IJ (eds) Better palliative care for older people. World Health Organization, p 21 WHO Europe (2004) Evidence of underassessment and undertreatment. In: Davies E, Higginson IJ (eds) Better palliative care for older people. World Health Organization, p 21
3.
go back to reference Statistics Netherlands (2001) Central Death Registry Statistics Netherlands (2001) Central Death Registry
4.
go back to reference Francke AL (2003) Palliative care for terminally ill patients in The Netherlands. Dutch government policy. The Hague: Ministry of Health, Welfare and Sport Francke AL (2003) Palliative care for terminally ill patients in The Netherlands. Dutch government policy. The Hague: Ministry of Health, Welfare and Sport
5.
go back to reference Visser G, Klinkenberg M, Broese van Groenou MI, Willems DL, Knipscheer CP, Deeg DJ (2004) The end of life: informal care for dying older people and its relationship to place of death. Palliat Med 18(5):468–477PubMedCrossRef Visser G, Klinkenberg M, Broese van Groenou MI, Willems DL, Knipscheer CP, Deeg DJ (2004) The end of life: informal care for dying older people and its relationship to place of death. Palliat Med 18(5):468–477PubMedCrossRef
6.
go back to reference Tang ST, McCorkle R (2003) Determinants of congruence between the preferred and actual place of death for terminally ill cancer patients. J Palliat Care 19(4):230–237PubMed Tang ST, McCorkle R (2003) Determinants of congruence between the preferred and actual place of death for terminally ill cancer patients. J Palliat Care 19(4):230–237PubMed
7.
go back to reference Klinkenberg M, Visser G, van Groenou MI, van der Wal G, Deeg DJ, Willems DL (2005) The last 3 months of life: care, transitions and the place of death of older people. Health Soc Care Community 13(5):420–430PubMedCrossRef Klinkenberg M, Visser G, van Groenou MI, van der Wal G, Deeg DJ, Willems DL (2005) The last 3 months of life: care, transitions and the place of death of older people. Health Soc Care Community 13(5):420–430PubMedCrossRef
8.
go back to reference Pritchard RS, Fisher ES, Teno JM, Sharp SM, Reding DJ, Knaus WA et al (1998) Influence of patient preferences and local health system characteristics on the place of death. SUPPORT investigators. Study to understand prognoses and preferences for risks and outcomes of treatment. J Am Geriatr Soc 46(10):1242–1250PubMed Pritchard RS, Fisher ES, Teno JM, Sharp SM, Reding DJ, Knaus WA et al (1998) Influence of patient preferences and local health system characteristics on the place of death. SUPPORT investigators. Study to understand prognoses and preferences for risks and outcomes of treatment. J Am Geriatr Soc 46(10):1242–1250PubMed
9.
go back to reference WHO Europe (2004) Policies for palliative care need to be developed as part of an innovative global public health policy. In: Davies E, Higginson IJ (eds) The solid facts, palliative care. World Health Organization, p 14 WHO Europe (2004) Policies for palliative care need to be developed as part of an innovative global public health policy. In: Davies E, Higginson IJ (eds) The solid facts, palliative care. World Health Organization, p 14
10.
go back to reference Plonk WM Jr, Arnold RM (2005) Terminal care: the last weeks of life. J Palliat Med 8(5):1042–1054PubMedCrossRef Plonk WM Jr, Arnold RM (2005) Terminal care: the last weeks of life. J Palliat Med 8(5):1042–1054PubMedCrossRef
11.
go back to reference Lynn JTJ, Phillips RS, Wu AW, Desbiens N, Harrold J, Claessens MT, Wenger N, Kreling B, Connors AF Jr (1997) Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT investigators. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med 126:97–106PubMed Lynn JTJ, Phillips RS, Wu AW, Desbiens N, Harrold J, Claessens MT, Wenger N, Kreling B, Connors AF Jr (1997) Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT investigators. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med 126:97–106PubMed
12.
go back to reference Toscani F, Di Giulio P, Brunelli C, Miccinesi G, Laquintana D (2005) How people die in hospital general wards: a descriptive study. J Pain Symptom Manage 30(1):33–40PubMedCrossRef Toscani F, Di Giulio P, Brunelli C, Miccinesi G, Laquintana D (2005) How people die in hospital general wards: a descriptive study. J Pain Symptom Manage 30(1):33–40PubMedCrossRef
13.
go back to reference DeSilva DL, Dillon JE, Teno JM (2001) The quality of care in the last month of life among Rhode Island nursing home residents. Med Health R I 84(6):195–198PubMed DeSilva DL, Dillon JE, Teno JM (2001) The quality of care in the last month of life among Rhode Island nursing home residents. Med Health R I 84(6):195–198PubMed
14.
go back to reference Hall P, Schroder C, Weaver L (2002) The last 48 hours of life in long-term care: a focused chart audit. J Am Geriatr Soc 50(3):501–506PubMedCrossRef Hall P, Schroder C, Weaver L (2002) The last 48 hours of life in long-term care: a focused chart audit. J Am Geriatr Soc 50(3):501–506PubMedCrossRef
15.
go back to reference Reynolds K, Henderson M, Schulman A, Hanson LC (2002) Needs of the dying in nursing homes. J Palliat Med 5(6):895–901PubMedCrossRef Reynolds K, Henderson M, Schulman A, Hanson LC (2002) Needs of the dying in nursing homes. J Palliat Med 5(6):895–901PubMedCrossRef
16.
go back to reference Teno JM, Clarridge BR, Casey V, Welch LC, Wetle T, Shield R et al (2004) Family perspectives on end-of-life care at the last place of care. JAMA 291(1):88–93PubMedCrossRef Teno JM, Clarridge BR, Casey V, Welch LC, Wetle T, Shield R et al (2004) Family perspectives on end-of-life care at the last place of care. JAMA 291(1):88–93PubMedCrossRef
17.
go back to reference Sneeuw KC, Aaronson NK, Sprangers MA, Detmar SB, Wever LD, Schornagel JH (1998) Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol 51(7):617–631PubMedCrossRef Sneeuw KC, Aaronson NK, Sprangers MA, Detmar SB, Wever LD, Schornagel JH (1998) Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol 51(7):617–631PubMedCrossRef
18.
go back to reference Coyle N, Adelhardt J, Foley KM, Portenoy RK (1990) Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage 5(2):83–93PubMedCrossRef Coyle N, Adelhardt J, Foley KM, Portenoy RK (1990) Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage 5(2):83–93PubMedCrossRef
19.
go back to reference Klinkenberg M, Willems DL, van der Wal G, Deeg DJ (2004) Symptom burden in the last week of life. J Pain Symptom Manage 27(1):5–13PubMedCrossRef Klinkenberg M, Willems DL, van der Wal G, Deeg DJ (2004) Symptom burden in the last week of life. J Pain Symptom Manage 27(1):5–13PubMedCrossRef
20.
go back to reference The SUPPORT Principal Investigators (1995) A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 274(20):1591–1598CrossRef The SUPPORT Principal Investigators (1995) A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 274(20):1591–1598CrossRef
21.
go back to reference Wenrich MD, Curtis JR, Shannon SE, Carline JD, Ambrozy DM, Ramsey PG (2001) Communicating with dying patients within the spectrum of medical care from terminal diagnosis to death. Arch Intern Med 161(6):868–874PubMedCrossRef Wenrich MD, Curtis JR, Shannon SE, Carline JD, Ambrozy DM, Ramsey PG (2001) Communicating with dying patients within the spectrum of medical care from terminal diagnosis to death. Arch Intern Med 161(6):868–874PubMedCrossRef
22.
go back to reference Osse BH, Vernooij-Dassen MJ, Schade E, de Vree B, van den Muijsenbergh ME, Grol RP (2002) Problems to discuss with cancer patients in palliative care: a comprehensive approach. Patient Educ Couns 47(3):195–204PubMedCrossRef Osse BH, Vernooij-Dassen MJ, Schade E, de Vree B, van den Muijsenbergh ME, Grol RP (2002) Problems to discuss with cancer patients in palliative care: a comprehensive approach. Patient Educ Couns 47(3):195–204PubMedCrossRef
23.
go back to reference Murray SA, Kendall M, Boyd K, Sheikh A (2005) Illness trajectories and palliative care. BMJ 330(7498):1007–1011PubMedCrossRef Murray SA, Kendall M, Boyd K, Sheikh A (2005) Illness trajectories and palliative care. BMJ 330(7498):1007–1011PubMedCrossRef
24.
go back to reference Albinsson L, Strang P (2003) Differences in supporting families of dementia patients and cancer patients: a palliative perspective. Palliat Med 17(4):359–367PubMedCrossRef Albinsson L, Strang P (2003) Differences in supporting families of dementia patients and cancer patients: a palliative perspective. Palliat Med 17(4):359–367PubMedCrossRef
Metadata
Title
The last 3 days of life in three different care settings in The Netherlands
Authors
Laetitia Veerbeek
Lia van Zuylen
Siebe J. Swart
Paul J. van der Maas
Agnes van der Heide
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 10/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0211-x

Other articles of this Issue 10/2007

Supportive Care in Cancer 10/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine